We have entered a new era of HER2-targeted therapy that is impossible to ignore
With the expansion into many other indications beyond breast cancer and into lower expression, the world of possibilities for HER2-therapies has opened greatly. With this, the number of players in this field has skyrocketed, and therefore so has the necessity for partners, collaborators, and solution providers to support this expansion.
This is your opportunity to become part of the HER2 global expansion and showcase your expertise in solution services.
If you provide services in tumor models, antibody manufacturing, clinical trials, diagnostics, biomarkers, or product development technology, now’s the time to get in front of the key decision-makers of the field.
Whether you need to communicate exciting progress, are looking to generate leads, or would like to understand what next-generation investments the market wants, you can rely on our ability to advise and deliver the right solution for you.
Get in touch today to learn more about bespoke partnership opportunities.